Publication | Open Access
Baseline Numbers of Circulating CD28-negative T Cells May Predict Clinical Response to Abatacept in Patients with Rheumatoid Arthritis
72
Citations
16
References
2011
Year
A simple laboratory measure, the baseline number of circulating CD28- T cells, predicted remission after 6 months of abatacept treatment in patients with RA.
| Year | Citations | |
|---|---|---|
Page 1
Page 1